Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

Phillips-Medisize Expands Clinical Manufacturing Capabilities to Serve Growing Drug Delivery Device Market

The company has repurposed its cleanroom to support late stage development of medium- and high-volume products and processes.

Phillips-Medisize’s manufacturing facility in Struer, Denmark will include a dedicated Manufacturing Development and Clinical build unit.
Phillips-Medisize’s manufacturing facility in Struer, Denmark will include a dedicated Manufacturing Development and Clinical build unit.

This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.

Phillips-Medisize, a Molex company, announced expansion of its current Global Innovation and Development (GID) site in Struer, Denmark with a dedicated Manufacturing Development and Clinical build unit, which is scheduled to open in the second quarter of 2020.  As a recognized global leader, Phillips-Medisize provides a wide range of custom drug delivery devices, connected health solutions and end-to-end manufacturing services worldwide.

The Phillips-Medisize manufacturing facility will be equipped to serve clients with agile set up for cleanroom assembly and molding (e.g. for clinical trials).  Approximately 500 m2 of floor space from the existing 8400 m2 building will be repurposed for the cleanroom.  The facility is designed to support late stage development of medium- and high-volume products and processes, under GMP and using state-of-the-art equipment. 

“This expansion accelerates the manufacture of innovative, compliant and best-in-class products while reducing time to market and lowering launch risk for drug delivery device customers,” said John Horgan, Vice President, Global Sales and Marketing of Phillips-Medisize.  “Furthermore, it strengthens our client focus in Scandinavia by complementing the activities of our existing GID in Struer and our newest GID in Copenhagen.”

FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report